
Pam Rajendran Taub MD
Non-Invasive Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation
Professor of Medicine, UCSD School of Medicine Director of Cardiac Wellness and Rehabilitation
Join to view full profile
9300 Campus Point DrLa Jolla, CA 92037
Phone+1 858-248-1308
Dr. Taub is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Pam R. Taub, MD, FACC, FASPC is a board-certified cardiologist and internationally recognized expert in cardiometabolic disease.
She is the director of Preventive Cardiology, the founding director of the Step Family Cardiac Rehabilitation and Wellness Center, and a Professor of Medicine with tenure at UC San Diego. She holds the Step Family Director's Endowed Chair. Dr. Taub was responsible for all aspects of creating the center, which is one of the largest comprehensive cardiac rehabilitation programs in the world. She also leads the newly formed BEACON center for Lipoprotein (a) research at UC San Diego.
Her clinical practice focuses on preventive cardiology, lipidology, and cardiometabolic disease, while her research investigates the impact of behavioral, technological, and pharmacological strategies on cardiometabolic health outcomes.
Dr. Taub is a federally funded researcher with continuous funding from the National Institutes of Health for the past 15 years, and is the principal investigator on multiple R01 grants. She has also received research funding from the Department of Defense, Department of Homeland Security, and American Heart Association. She is an experienced clinical trialist and serves on the executive committee for multiple international clinical trials focused on novel cardiovascular therapies.
Dr. Taub holds multiple patents, edited multiple textbooks, and is widely published with over 150 high-impact publications in top peer-reviewed journals that have impacted clinical practice. She also has served on multiple guideline committees and, most recently, on the 2025 AHA/ACC guidelines for management of patients with acute coronary syndrome.
Dr. Taub holds multiple leadership positions in professional societies. She is a fellow and a former board member of the American Society of Preventive Cardiology, a fellow and prior member of the American College of Cardiology's Prevention of Cardiovascular Disease Leadership Council. Currently, sh
Education & Training
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2007 - 2010
University of WashingtonResidency, Internal Medicine, 2005 - 2007
Boston University School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - 2028
WA State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function
- Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
- Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
Publications & Presentations
PubMed
- Sodium-relevant comorbidity risk factors are highly prevalent in individuals with narcolepsy or idiopathic hypersomnia.Sarah C Markt, Caroleen Drachenberg, Richard J Kovacs, Pam Taub, Kaitlyn Easson
Sleep Medicine. 2026-09-01 - Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults.Shady Abohashem, Seth S Martin, Ibrahim Hassan, Samia Mora, Pam R Taub
JAMA. 2026-08-18 - Preventing Heart Failure: At-Risk Populations and the Role of Biomarkers.Mark C Petrie, James L Januzzi, Josephine Harrington, Pam Taub, Antonio Bayes-Genis
Journal of the American College of Cardiology. 2026-08-04
Journal Articles
- Correction to: Mitochondrial H+-ATP Synthase in Human Skeletal Muscle: Contribution to Dyslipidaemia and Insulin ResistancePam Taub, Robert R Henry, Diabetologia
Lectures
- Pearls In Lifestyle Related Prevention Every Cardiology Practitioner Needs to Know2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- The Mind-Body-Heart Connection: What's the evidence?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Barriers to Cardiac Rehabilitation: How Do We Overcome Issues With Adherence and Cost?2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Press Mentions
Endowed Director’s Chair in Cardiovascular Rehabilitation and Wellness Established at UC San DiegoOctober 15th, 2025
Statin Alternative Slashes Bad Levels by 48%June 17th, 2025
New Center Focused on Lp(A) Established in UC San DiegoJune 17th, 2025
Grant Support
- Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic SyndromeUNIVERSITY OF CALIFORNIA, SAN DIEGO2018–2030
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








